BCRX EPS Estimates
BioCryst Pharmaceuticals, Inc.
$8.19
+$0.13(+1.68%)
39
Overall
60
Value
10
Tech
47
Quality
Market Cap
$2.06B
Volume
567.59K
52W Range
$6.00 - $11.22
Target Price
$20.45
BCRX EPS estimates: the consensus estimate for BioCryst Pharmaceuticals, Inc.'s current fiscal year is -$2.28 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BCRX EPS Estimates
- EPS estimate, current quarter
- $0.10
- EPS estimate, next quarter
- $0.11
- EPS estimate, current year
- $-2.28
- EPS estimate, next year
- $0.69
- EPS growth, 3-year
- +43.38%
| Fiscal year | EPS |
|---|---|
| 2025 | $1.26 |
| 2024 | $-0.43 |
| 2023 | $-1.18 |
| 2022 | $-1.33 |
| 2021 | $-1.03 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $8.19 | +1.7% | 567.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW